Learn more about how Cyprotex can support you in understanding the metabolism of your compounds by identifying which metabolites are formed during in vitro and in vivo studies.
Read our fact sheet to learn more about our metabolite profiling and identification service.
Tags: Fact Sheets, ADME/DMPK, IND Enabling Studies/Preclinical Development, Cyprotex
Drug-induced liver injury (DILI) is a major cause of drug attrition - responsible for 18% of drug withdrawals from the market.
Learn more about how Cyprotex can support you in understanding potential DILI risk of your test article.
Tags: Fact Sheets, Toxicology & Safety, Cyprotex
Cardiotoxicity is a major cause of drug attrition accounting for 45% of all drugs taken off the market between 1994 and 2006.
Learn more about how Cyprotex can support you in understanding the potential risk of cardiotoxicity of your test article.
Tags: Fact Sheets, Toxicology & Safety, Cyprotex
Cell painting analyses phenotypic changes in cells following dosing with test articles. It can be used to assess potential toxicity risks.
Read our fact sheet to learn more about how Cyprotex can support you in understanding the potential risk of toxicity using cell painting.
Tags: Fact Sheets, Toxicology & Safety, Cyprotex
Date: November, 17-20
Location: Austin, TX, USA
Attending:
Date: September, 08-11
Location: Copenhagen, Denmark
Attending:
Date: July 03-05
Location: Fukuoka City, Japan
Attending
Learn more about JSOT (The 51st Annual Meeting of the Japanese Society of Toxicology)
Date: May 21-23
Location: Tel-Aviv, Israel
Attending
Date: May 08-10
Location: Seoul, South Korea
Attending
Date: April 25
Location: GSK Conference Centre, Stevenage, UK
Attending
Learn more about 35th Medicinal Chemistry in Eastern England